Amubarvimab
Product Sizes
1 mg
£ POA
HY-P99435-1MG
10 mg
£ POA
HY-P99435-10MG
5 mg
£ POA
HY-P99435-5MG
About this Product
- SKU:
- HY-P99435
- Additional Names:
- BRII-196
- CAS Number:
- 2509447-07-6
- Extra Details:
- Amubarvimab (BRII-196) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein; with a KD of 5.88 nM. Amubarvimab can effectively neutralize SARS-CoV-2 variants[1][2].
- Molecular Weight:
- (143.84 kDa)
- Purity:
- 95.00
- References:
- [1]Ji Y, et, al. Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2. Front Immunol. 2022 Sep 14;13:980435. |[2]Hoy SM. Amubarvimab/Romlusevimab: First Approval. Drug. 2022 Aug;82(12):1327-1331.
- Research Area:
- Infection
- Shipping Conditions:
- Dry Ice
- Storage Conditions:
- Store at -80[o]C for 2 years
- Type:
- Antibodies
- Pathway:
- Anti-infection
